HKSE · 0673.HK
China Health Group Limited
HK$0.26HK$0.00 (0.0%)
China Health Group Limited’s quoted price sits in the lower half of its reported 52-week range, 69.77% below the high.
Loading market information…
HKSE · 8622.HK · HKD
Stock price, earnings
Quote as of Oct 30, 2026, 02:05 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
Joyzyme Group Limited’s quoted price sits in the lower half of its reported 52-week range, 69.33% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Joyzyme Group Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Huakang Biomedical Holdings Company Limited operates as an investment holding firm, primarily dedicated to the research, development, manufacturing, marketing, and distribution of in-vitro diagnostic (IVD) reagents within the People's Republic of China. Its comprehensive product portfolio encompasses IVD reagents designed for assessing male and female fertility, detecting parasite antibodies, and identifying the Epstein-Barr virus. Additionally, the company provides auxiliary reproductive supplies and equipment, alongside a range of healthcare products and nutritional supplements marketed under its 'Nutronic' brand, which are sold through both digital and physical platforms. Products are distributed directly to hospitals and medical institutions, as well as through a network of third-party distributors. The company was founded in 1992 and maintains its headquarters in Wan Chai, Hong Kong.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:34 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
HK$0.26HK$0.00 (0.0%)
China Health Group Limited’s quoted price sits in the lower half of its reported 52-week range, 69.77% below the high.
HK$0.87+HK$0.02 (+2.35%)
Regent Pacific Group Limited’s quoted price sits in the lower half of its reported 52-week range, 28.69% below the high.
HK$0.25+HK$0.00 (+0.82%)
Tycoon Group Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 36.36% below the high.
HK$0.09HK$0.00 (0.0%)
Tianda Pharmaceuticals Limited’s quoted price sits in the lower half of its reported 52-week range, 35.97% below the high.
HK$0.11+HK$0.00 (+0.91%)
Shenzhen Neptunus Interlong Bio-technique Company Limited’s quoted price sits in the lower half of its reported 52-week range, 37.99% below the high.
HK$0.41-HK$0.02 (-4.71%)
Bamboos Health Care Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 30.17% below the high.
HK$0.03HK$0.00 (0.0%)
Tai United Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 44.44% below the high.
HK$0.05HK$0.00 (0.0%)
Extrawell Pharmaceutical Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 55.65% below the high.
